Scientists are not yet very optimistic about producing fully functional artificial blood in the near future. As a result, blood donation is expected to remain essential for many years. Creating insulin through genetic engineering is relatively simple because insulin is a single protein with a straightforward structure. Blood, however, is much more complex. It contains multiple types of cells, proteins, and other components that work together to perform vital functions. This complexity makes laboratory production of blood extremely challenging.
Ads
Researchers can already produce certain blood components, such as red blood cells and hemoglobin, using advanced biotechnological methods. Hemoglobin is a protein that gives blood its red color and is responsible for carrying oxygen to muscles, tissues, and organs throughout the body. Today, genetically engineered hemoglobin is sometimes used as a blood substitute or blood replacement product, particularly in emergency situations where immediate blood supply is needed. However, these products cannot fully replace natural human blood.
Ads
The liquid portion of blood, known as plasma, contains various blood cells and proteins, each performing specific and important roles. Scientists have successfully developed several blood-related components in laboratories through genetic engineering. These innovations can help perform some of the essential functions of blood, but they cannot replicate all of its capabilities. For this reason, laboratory-made blood products are currently limited to specialized medical applications. While scientific progress continues, a complete artificial replacement for human blood remains beyond current technological capabilities.
